logoeu-poig (1)

The project received financial support from The National Centre for Research and Development, from the Innovative Economy Programme under the European Regional Development Fund

Please be advised that PozLab sp. z o.o.is the partner in the Project INNOMED:

Development of technology for obtaining cannabinoids from low-THC-content cannabis species, as  means of supporting cancer treatment
Acronym: ONKOKAN

agreement number: INNOMED/I/11/NCBR/2014

Project Leader: Poznan University of Life Science, Department of Biochemistry and Biotechnology

 

Contact

ONKOKAN Project Manager
Prof. dr. hab. Ryszard Slomski
Department of Biochemistry and Biotechnology
Poznan University of Life Science
11 Dojazd Street, PL60632 Poznan, Poland
slomski@up.poznan.pl
phone: +48 61 8487202

Office of the Project Leader – Project Service ONKOKAN
Emilia Smolińska
Department of Biochemistry and Biotechnology
Poznan University of Life Science
11 Dojazd Street, PL60632 Poznan, Poland
emilasmo@up.poznan.pl
phone: +48 61 8466489

 

The project is implemented under the program INNOMED from The National Centreer for Research and Development from the Innovative Economy Programme under the European Regional Development Fund

 

Partners

Institute of Natural Fibres&Medicinal Plants
Poznan University of Medical Sciences
Poznan Institute of Human Genetics, Polish Academy of Sciences
PozLab sp. z o. o.
Laboratory of Molecular Genetics

Tasks

Nine major tasks is scheduled within the project.
Pozlab is responsible for:

  1. Preformulation studies of extracts obtained from Cannabis sativa and auxiliary substances necessary to obtain mucoadhesive drug dosage form
  2. Development of mucoadhesive tablet formulation, including stability studies and manufacturing process scale-up principles

INFRASTRUKTURA_I_SRODOWISKO_LONGEU_cent-kolor INNOWACYJNA_GOSPODARKA_LONG